Table 1 Spectrum of germline BHD mutations and phenotypic features of 51 National Cancer Institute families with Birt–Hogg–Dubé syndrome
Family IDMutation analysisPhenotype in family members
IntronExonNucleotide changeCodon locationMutation typeNo. clinical affectedNo. with FFOther skin lesionsNo. with renal tumoursNo. with lung cystsNo. with pneumo-thorax
2514c.514delT†F20Deletion11TD, BCC000
2524c.602delAE49Deletion11011 (n = 3)
2534IVS4-2A>GSplice site11011 (n = 1)
2404IVS4-2A>GSplice site109TD, PFF140
2544IVS4-2A>GSplice site11TD110
2554IVS4-2A>GSplice site11PFF011 (n = 2)
256*5c.751delAD99Deletion10PFF111 (n = 5)
17985c.774-5delGTinsCACV107Deletion/ insertion11TD010
2575c.774-5delGTinsCACV107Deletion/ insertion43PFF, SH040
2585c.802insAQ116Insertion11LM111 (n = 17)
2596c.1039delG†G195Deletion11110
2606c.1039delG†G195Deletion11SH, PFF011 (n = 1)
17516c.1065-6delGCinsTAA204XNonsense44AF, BCC042 (n = 2)
2617IVS7+1 G>TSplice site11L111 (n = 3)
2627IVS7+1 G>TSplice site54AF, DFSP, LS, TD451 (n = 1)
263*7IVS7+1 G>TSplice site11111 (n = 1)
2649c.1378-1405dupT317Insertion11PFF110
2659c.1378-1405dupT317Insertion22PFF122 (n = 4)
2669c.1378-1405dupT317Insertion11TD010
2679IVS9+2 T>GSplice site11010
26811c.1670C>GY405XNonsense11DF110
26911c.1707delCL418Deletion10AF, SH, SCC010
27011c.1733insCH429Insertion11MM, L100
27111c.1733insCH429Insertion22TD, PFF, CTN010
27211c.1733insCH429Insertion11BCC, PFF010
27311c.1733insCH429Insertion11PFF010
27411c.1733insCH429Insertion11PFF, SH011 (n = 4)
27511c.1733insCH429Insertion22121 (n = 5)
27611c.1733insCH429Insertion11BCC000
27711c.1733insCH429Insertion22PFF020
27811c.1733insCH429Insertion32PFF020
279*11c.1733insCH429Insertion22221 (n = 1)
28011c.1733insCH429Insertion32AF, CTN033 (n = 5)
28111c.1733insCH429Insertion22AF021 (n = 5)
28211c.1733insCH429Insertion11110
28311c.1733insCH429Insertion32131 (n = 1)
28411c.1733delCH429Deletion43L, MM143 (n = 4)
285*11c.1733delCH429Deletion11111 (n = 7)
28611c.1733delCH429Deletion11010
28711c.1733delCH429Deletion10TD111 (n = 1)
28811c.1733delCH429Deletion22AF220
28911c.1741insAH429Insertion11BCC, SCC011 (n = 3)
290*11c.1755G>CE434QSplice site11100
291*11c.1755G>AE434KSplice site21PFF121 (n = 4)
29212c.1834-5delTCL460Deletion11111 (n = 1)
29312c.1844C>GY463XNonsense22AF021 (n = 2)
29412c.1844C>GY463XNonsense10PFF, AF000
29512c.1844C>GY463XNonsense11AF111 (n = 4)
29612IVS12+1G>ASplice site11TD, PFF011
297*13c.1978A>GK508RMissense100100
29813c.1983-5delGAGE510Deletion21AF022 (n = 4)
Totals: 51 families89753075
  • AF, angiofibroma; BCC, basal cell carcinoma; CTN, connective tissue nevus; DFSP, dermatofibrosarcoma protuberans; FF, fibrofolliculoma; L, lipoma; LM, cutaneous leiomyoma; MM, malignant melanoma; PFF, perifollicular fibroma; LS, cutaneous leiomyosarcoma; SCC, squamous cell carcinoma; SH, sebaceous hyperplasia; TD, trichodiscoma.

  • FF diagnosis is based on histological diagnosis only.

  • *Families ascertained on the basis of kidney tumours. †In these cases of deletions in a mononuclear tract, the last nucleotide is given. The c.514delT mutation was formerly reported as c.513delT and the c.1039delG was formerly reported as c. 1036delG.